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Abstract
OBJECTIVE: To determine the distribution of Tradi-
tional Chinese Medicine (TCM) patterns in hepatitis
B-related acute-on-chronic liver failure (HB-ACLF)
in different stages for guiding clinical prescriptions
and treatments.
METHODS: A prospective, cross-sectional survey
method was used in this study. A total of 324 cases
with HB-ACLF in China were involved.
RESULTS: The general frequency of TCM patterns
in HB-ACLF were as follows: Heat Toxin Stagnation
Pattern (134/324, 41.36%), Damp-heat Obstruction
Pattern (66/324, 20.37% ), Yang Qi Deficiency Pat-
tern (52/324, 16.05%), and Liver and Kidney Yin De-
ficiency Pattern (26/324, 8.02%). In the early stage
of HB-ACLF, there was a remarkably higher percent-
age of excessive patterns than those in the middle
and late stage. The incidence of Heat Toxin Stagna-
tion reached 58.57% (82/140) in the early stage,
while it was 33.96% (36/106) in the middle stage
and 20.51% (16/78) in the late stage. In the early
stage of HB-ACLF, excessive patterns, such as the
Heat Toxin Stagnation Pattern, were more preva-
lent than those in the middle and late stages (P<α′=
0.003). However, in the late stage of HB-ACLF, defi-
cient patterns, such as the Yang Qi Deficiency Pat-
tern, were more prevalent than those in the early
and middle stages. The Yang Qi Deficiency Pattern
had a higher rate of 41.03% (32/78) in the late
stage compared with that of 20.75% (22/106) in the
middle stage and 8.57% (12/140, P<α′ =0.003) in
the early stage. The distribution of the other pat-
terns was not significant between the three stages
(P>0.003).
CONCLUSIONS: There are four major patterns of
HB-ACLF, including the Heat Toxin Stagnation Pat-
tern, the Damp-heat Obstruction Pattern, the Yang
Qi Deficiency Pattern, and the Liver and Kidney Yin
Deficiency Pattern. The Heat Toxin Stagnation and
Yang Qi Deficiency Patterns are the representative
patterns in the early and late stages of HB-ACLF. In
the middle stage of HB-ACLF, the TCM patterns vary
in a complicated manner, with no significant differ-
ence among the patterns. Treatment for HB-ACLF
should vary with the different representative pat-
terns in the early and late stages.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Acute-on-chronic liver failure (ACLF) is a severe liver
disease. ACLF develops from chronic liver diseases un-
der acute occasions, manifesting as jaundice and distur-
bance of blood coagulation, with complications of asci-
tes and (or) hepatic encephalopathy within 4 weeks.
Hitendra Garg1 showed that 30% to 50% of ACLF pa-
tients have liver-related complications and most of
them die of multiple organ dysfunction. Approximate-
ly 75% of untreated ACLF patients die,2 and therefore
it is an acute and severe disease. The three main causes
of ACLF are hepatitis B virus (HBV) infection
(90.29%), alcoholic liver disease (2.65%), and superin-
fection of HBV and hepatitis E virus (HEV) (2.26%).3
An epidemiological study on TCM patterns of hepati-
tis B-related (HB)-ACLF in different stages would be
useful for classification and treatment, as well as basic
data for establishment of national medicare policies. In
recent years, there has been little research on TCM pat-
terns of chronic severe hepatitis, of which diagnostic
criteria were determined at the 10th National Viral
Hepatitis Conference in 2000, Xi'an. None of these di-
agnostic criteria are on the basis of the diagnostic stan-
dard given in the Guideline of Diagnosis and Treat-
ment of Liver Failure in 2006.
We collected data on 324 HB-ACLF inpatients of the
Sichuan Region and determined the distribution of the
TCM patterns for HB-ACLF in different stages to
guide clinical prescriptions and treatments.
METHODS
Patients
This prospective, cross-sectional survey was conducted
using data of 324 inpatients who were admitted to the
Affiliated Hospital of Chengdu University of Chinese
Medicine from September 2007 to October 2009.
This study was approved by the appropriate ethics com-
mittees and was performed in accordance with the ethi-
cal standards laid down in the Declaration of Helsinki.
All persons signed their informed consent prior to their
inclusion in the study.
Diagnostic standard
According to the Guideline for the Diagnosis and Treat-
ment of Liver Failure4 formulated in 2006 by the Chi-
nese Academic Association of Infectious Diseases and
the Chinese Academic Association of Liver Diseases,
ACLF is a rapid and acute liver disease based on chron-
ic liver disease, and is divided into three stages. In the
early stage, symptoms are as follows: 1) extreme fatigue
with severe digestive symptoms, such as obvious an-
orexia, vomiting, and abdominal distention; 2) aggres-
sive jaundice (serum bilirubin ≥171 μmol/L or a daily
increase by ≥17.1 μmol/L); 3) a trend of hemorrhage,
with 30% <prothrombin activity (PTA) ≤40%; and 4)
no symptoms of hepatic encephalopathy or obvious as-
cites. In the middle stage, patients either have liver en-
cephalopathy below the second degree and (or) obvi-
ous ascites, or an obvious trend of hemorrhage (bleed-
ing point or suggillation), with 20% <PTA ≤30%. In
the late stage, patients become worse with any one of
the following conditions: 1) intractable complications,
such as hepatorenal syndrome, massive hemorrhage of
the upper gastrointestinal tract, serious infection, and
intractable electrolyte disturbance; 2) hepatic encepha-
lopathy beyond the third degree; and 3) a severe trend
of hemorrhage (petechiae in the injection position),
with PTA ≤20%.
Exclusion criteria
Exclusion criteria were as follows: 1) acute liver failure,
sub-acute liver failure, and chronic liver failure; 2)
non-HBV-infection related ACLF; 3) pregnant or lac-
tating women; 4) patients with primary liver cancer; 5)
patients with other serious systemic or psychiatric dis-
eases; 6) patients younger than 18 years or older than
65 years.
Inclusion criteria
Inclusion criteria were 1) inpatients in accordance with
the above-mentioned diagnostic criteria; 2) patients
without any one item of exclusion criteria; 3) patients
who coordinated with doctors; 4) patients who had the
necessary clinical examinations.
Collection of patient's data
Every patient was examined by two trained researchers
and their information was analyzed with a prospective,
cross-sectional survey method. The valid information
collection period was within 24 h from patients' confir-
mation of HB-ACLF. If the two researchers disagreed
about the TCM syndrome differentiation, the case was
excluded from the study.
Criteria of TCM differentiation and diagnosis
The criteria of TCM differentiation and diagnosis ref-
fered to the TCM Differentiation Criteria on Viral
Hepatitis Draft5 formulated by the Chinese TCM Aca-
demic Association of Hepatic Diseases, the Guidelines
for Clinical Research on Chinese New Herbal Treat-
ment on viral hepatitis formulated by the Sino-Food
and Drug Administration6, and other sources.7
Heat Toxin Stagnation Pattern: Major symptoms of the
Heat Toxin Stagnation Pattern were as follows: 1) yel-
low and normal urine; 2) skin itching, bleeding point
after scratching, or a burning sensation; 3) purple and
dark tongue with suggillation, and an enlarged and pro-
longed sublingual vein.
Minor symptoms were as follows: 1) feeling thirsty but
drinking little; 2) dry stool; 3) bleeding nose and
gums, or suggillation in the skin; 4) undesirable hypo-
chondrial mass; 5) less tongue coating, a thin and
white coating or a thin and yellow coating, or a wiry,
or wiry and choppy pulse.
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Diagnostic criteria: 1) all major symptoms were pres-
ent; and 2) two of the three major symptoms and two
of the five minor symptoms were present.
Damp-heat Obstruction Pattern: major symptoms of
the Damp-heat Obstruction Pattern were as follows: 1)
jaundice of the body, and the eyes are a bright yellow
color; 2) a yellow and greasy tongue coating.
Minor symptoms of the Damp-heat Obstruction Pat-
tern were as follows: 1) nausea, aversion to oil, and
poor appetite; 2) hypochondrial distention and abdom-
inal fullness; and 3) yellow urine.
Diagnostic criteria: 1) two major symptoms were pres-
ent; 2) major symptom 2) and any two of the three mi-
nor symptoms were present; and 3) major symptom 1)
and minor symptoms 1) and 2) were present.
Yang Qi Deficiency Pattern: major symptoms of the
Yang Qi deficiency pattern were as follows: 1) chilly
and cold limbs; and 2) fatigue and a weak pulse.
Minor symptoms of the Yang Qi Deficiency Pattern
were as follows: 1) cold sensation and pain in the hypo-
gastrium, waist and knees; 2) bad appetite and diarrhea
even in the morning; 3) lower limb edema; and 4) a
clammy scrotum.
Diagnostic criteria: 1) two major symptoms were pres-
ent; 2) major symptom 1) or 2) and any two of the
four minor symptoms were present; 3) the first three
minor symptoms were present, or for males, any two of
the first three minor symptoms and minor symptom 4).
Spleen Failing to Control Blood Pattern: Major symp-
toms of the Spleen Failing to Control Blood Pattern
were as follows: 1) bleeding nose and gums, suggilla-
tion, hamatemesis, and hematochezia; 2) jaundice,
with a dark yellow color in the whole body.
Minor symptoms of the Spleen Failing to Control
Blood Pattern were as follows: 1) energy sag; 2) fatigue
and bad appetite; and 3) a pale tongue, and deep and
thin pulse.
Diagnostic criteria: 1) two major symptoms and any two
of the three major symptoms were present; 2) one major
symptomand all threeminor symptomswere present.
Turbid Dampness Overflowing Pattern: major symp-
toms of the Turbid Dampness Overflowing Pattern were
as follows: 1) wandering mind; 2) jaundice, with a dark
yellow color in thewhole body; and 3) loose stool.
Minor symptoms of the Turbid Dampness Overflow-
ing Pattern were as follows: 1) oliguria; 2) bad appetite
or vomiting; and 3) a soggy and choppy pulse.
Diagnostic criteria: 1) all major symptoms were pres-
ent; 2) major symptoms both 1) and 2), or 3), and any
two of the three minor symptoms were present; and 3)
major symptom 1) and all three minor symptoms were
present.
Yin and Yang Separation and Collapse Pattern: major
symptoms of the Yin and Yang Separation and Col-
lapse Pattern were as follows: 1) coma; 2) polypnea;
and 3) dark facial color with red cheeks.
Minor symptoms of the Yin and Yang Separation and
Collapse Pattern were as follows: 1) urinary and fecal
incontinence; 2) sweating severely; and 3) an enlarged
and hollow pulse or a slippery, faint and thin pulse.
Diagnostic criteria: 1) all major symptoms were pres-
ent; 2) major symptoms both 1) and 2), or 3), and any
two of the three minor symptoms were present; 3) ma-
jor symptom 1) and all three minor symptoms were
present.
Liver and Kidney Yin Deficiency Pattern: major symp-
toms of the Liver and Kidney Yin Deficiency Pattern
were as follows: 1) dizziness and blurred vision; 2) ach-
ing and weakness of the waist and knees; and 3) a red
tongue with little fluid.
Minor symptoms of the Liver and Kidney Yin Defi-
ciency Pattern were as follows: 1) heat in the chest,
palms and soles; 2) insomnia with dreams; 3) pain in
the hypochondrial region, which is aggravated when fa-
tigued; and 4) a thin and rapid pulse.
Diagnostic criteria: 1) all major symptoms were pres-
ent; 2) any two major symptoms and any two of the
four minor symptoms were present; 3) any one major
symptom and any three minor symptoms were present;
and 4) all minor symptoms were present.
Liver Depression and Spleen Deficiency Pattern: major
symptoms of the Liver Depression and Spleen Deficien-
cy Pattern were as follows: 1) hypochondrial distending
pain; and 2) abdominal distention with loose stool.
Minor symptoms of the Liver Depression and SpleenDe-
ficiency Pattern were as follows: 1) depression and vexa-
tion; 2) fatigue; and 3) a pale tonguewith teeth prints.
Diagnostic criteria: 1) two major symptoms were pres-
ent; 2) major symptom 1) and minor symptoms 2) and
3) were present; 3) major symptom 2) and minor
symptom 1) were present.
Dampness Obstructing the Spleen and Stomach Pat-
tern: major symptoms of the Dampness Obstructing
the Spleen and Stomach Pattern were as follows: 1)
stomach fullness with a poor appetite; and 2) a greasy
tongue coating.
Minor symptoms of the Dampness Obstructing the
Spleen and Stomach Pattern were as follows: 1) heavy
sensation of limbs; 2) sticky sensation in the mouth;
and 3) loose stool and diarrhea.
Diagnostic criteria: 1) two major symptoms were pres-
ent; 2) one major symptom and two minor symptoms
were present.
Stasis-heat and Phlegm Obstruction Pattern: Major
symptoms of the Stasis-heat and Phlegm Obstruction
Pattern were as follows: 1) a long period of jaundice
with a dark color; and 2) itchy skin.
Minor symptoms of the Stasis-heat and Phlegm Ob-
struction Pattern were as follows: 1) a dark red tongue;
2) distending pain at the right hypochondrial region;
and 3) stool with a light color or gray color.
Diagnostic criteria: 1) major symptom 2) was present;
2) major symptom 1) and two minor symptoms were
present.
Liver Depression and Qi Stagnation Pattern: major
symptoms of the Liver Depression and Qi Stagnation
Pattern were as follows: 1) hypochondrial distending
pain; and 2) a wiry pulse.
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Minor symptoms of the Liver Depression and Qi Stag-
nation Pattern were as follows: 1) poor appetite; 2) diz-
ziness; 3) depressive mood; and 4) for females: irregu-
lar menstruation and distending sensation of the
breasts during menses.
Diagnostic criteria: 1) two major symptoms were pres-
ent; 2) major symptom 1) and two minor symptoms
were present; 3) major symptom 2) and three minor
symptoms were present.
Typing of HBV Genotypes/subgenotypes
Genotyping was based on S-gene sequences encompass-
ing the reverse-transcriptase domain of HBV, which
was amplified by an in-house nested PCR assay as pre-
viously described.8 The entire 1225 bp fragments (nt
54-1278) amplified were directly sequenced. HBV gen-
otypes and subgenotypes were determined by molecu-
lar evolutionary analysis of the viral sequences using
MEGA 4 software (www.megasoftware.net). Phyloge-
netic trees were constructed using neighbor-joining
analysis with bootstrap test confirmation performed on
1000 resamplings. Standard reference sequences were
acquired from the online Hepatitis Virus Database
(http://www.ncbi.nlm.nih.gov/projects/genotyping/
formpage.cgi) as previously reported.9
Research flow chart
A flow chart of the research is shown in Figure 1.
Statistics analysis
We analyzed the data with SPSS 17.0 (Cabit Informa-
tion Technology Co, Ltd). The trial used R×C test sta-
tistical methods, and P<0.01 indicated the distribution
of the TCM patterns in the different stages showed a
significant difference. The Bonferroni method was
used to adjust for multiple comparisons, which was P<α'=2α/k(k-1)=0.003, for comparison among the groups,
and this showed whether there was a significant differ-
ence of the constituent ratio of the TCM patterns in
the different stages.
RESULTS
Clinical data
Among the 324 HB-ACLF inpatients studied from
September 2007 to October 2009, 236 were male pa-
tients (72.84%) and 88 were female patients (27.16%),
aged 19-65 years [(44±9) years old]. There were 140,
106, and 78 cases in the early, middle and late stages,
respectively.
Baseline information
The patients' basic information, laboratory informa-
tion, and complications are shown in Table 1.
The Relationship between TCM patterns and
clinical stages in HB-ACLF cases
The distribution of TCM patterns in the 324
HB-ACLF cases were as follows. In the early stage of
HB-ACLF, the main patterns were the Heat Toxin Stag-
nation Pattern (82/140, 58.57%), the Damp-heat Ob-
struction Pattern (22/140, 15.71%), the Yang Qi Defi-
ciency Pattern (12/140, 8.57%), and the Liver and Kid-
ney Yin Deficiency Pattern (8/140, 5.71% ). In the
middle stage, the main patterns were the Heat Toxin
Stagnation Pattern (36/106, 33.96%), the Damp-heat
Obstruction Pattern (20/106, 18.87% ), the Yang Qi
Deficiency Pattern (22/106, 20.75% ), and the Liver
and Kidney Yin Deficiency Pattern (12/106, 11.32%).
In the late stage, the main patterns were the Yang Qi
Deficiency Pattern (32/78, 41.03% ), the Heat Toxin
Stagnation Pattern (16/78, 20.51% ), the Damp-heat
Obstruction Pattern (10/78, 12.82% ), and the Liver
and Kidney Yin Deficiency Pattern (6/78, 7.69%). The
TCM patterns were processed into binomial informa-
tion (positive and negative) with the R × C test. The
Heat Toxin Stagnation Pattern and Yang Qi Deficiency
Pattern had a significant difference in the distribution
of different stages, that is, the Heat Toxin Stagnation
and Yang Qi Deficiency Patterns were the representa-
tive patterns in the early and late stages of HB-ACLF.
However, the other patterns, including Damp-heat Ob-
struction, Liver and Kidney Yin Deficiency, Liver De-
pression and Spleen Deficiency, Dampness Obstruct-
ing the Spleen and Stomach, Stasis-heat and Phlegm
Obstruction, and Liver Depression with Qi Stagnation,
did not show any significant differences in the distribu-
tion of different stages (P>0.05, Table 2).
The incidence of the Heat Toxin Stagnation Pattern in
the early stage was much higher than that in the mid-
dle and later stages (P<α′ =0.003, Table 3). The inci-
dence of the Yang Qi Deficiency Pattern was higher in
the late stage than that in the early and middle stages.
(P<α′=0.003, Table 4).
HB-ACLF patients
Inclusion criteria Informed consent
n=324
Early stage
(n=140)
Middle stage
(n=106)
Late stage
(n=78)
Classification for TCM patterns after diagnosis of HB-ACLF
Discussion of relationship between TCM patterns of HB-ACLF
and clinical stages:
(1) comparison of TCM patterns in different stages;
(2) comparison of representative patterns in each two stages.
Figure 1 Flow chart of the research
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DISCUSSION
The diagnostic criteria of liver failure have been rapidly
updated in recent years. Liver failure is a syndrome
with characteristics of hepatic encephalopathy and co-
agulation disturbance caused by acute hepatocyte ne-
crosis or progressive liver function impairment. In
2000, the 10th National Viral Hepatitis Conference in
Xi'an, China changed the diagnostic criteria of severe
hepatitis10 and confirmed the diagnostic criteria of he-
patic failure. In 2005, the American Association for the
Study of Liver Failure issued the Management of Acute
Liver Failure.11 In 2006, the Liver Failure and Artificial
Liver Group of the Chinese Society of Infectious Dis-
eases and the Severe Liver Diseases and Artificial Liver
Table 3 Distribution of the Heat-toxin Stagnation Pattern in
the three stages of HB-ACLF
Stage
Early
Middle
Late
Total
Positive
82
36
16
134
Negative
58
70
62
190
Total
140
106
78
324
Positive
Rate (%)
58.57ab
33.96
20.51
44.95
Notes: HB-ACLF: hepatitis B-related acute-on-chronic liver
failure; aP<0.003, χ2=14.638, compared with middle stage;
bP<0.003, χ2=14.638, compared with late stage.
Table 4 Distribution of the Yang Qi Deficiency Pattern in the
three stages of HB-ACLF
Stage
Late
Middle
Early
Total
Positive
32
22
12
44
Negative
46
84
128
174
Total
78
106
140
218
Positive
Rate (%)
41.03ab
20.75
8.57
20.18
Notes: HB-ACLF: hepatitis B-related acute-on-chronic liver
failure; aP<0.003, χ2=13.429, compared with middle stage;
bP<0.003, χ2=32.751, compared with early stage.
Notes: HB-ACLF: hepatitis B-related acute-on-chronic liver failure;TBIL: total bilirubin; ALT: alanine aminotransferase;HBV: hepatitis B
virus; PTA: prothrombin activity;
Table 1 Baseline analysis of the 324 HB-ACLF cases
Demographic Data
Sex (male/female)
Age [year (range)]
Genotype B [n (%)]
Genotype C [n (%)]
Genotype D [n (%)]
-
-
-
236/88
44 (19-65）
104 (32.10)
217 (66.98)
3 (0.93)
-
-
-
Laboratory Data
TBIL (μmol/L)
ALT (IU/L)
HBV DNA
(logcps/mL)
HBeAg+ [n (%)]
PTA
CPT score
MELD score
468±122
325±96
6±2
122 (37.7)
28±10
9±4
25±12
Complication
Ascites [n (%)]
Infection [n (%)]
Gastrointestinal hemorrhage
Encephalopathy [n (%)]
I-II [n (%)]
III-IV [n (%)]
Hepatorenal syndrome
I [n (%)]
II [n (%)]
268 (82.7)
141 (43.5)
33 (10.2)
107 (33.0)
54 (16.7)
6 (1.9)
5 (1.5)
Table 2 TCM patterns of 324 HB-ACLF cases
Pattern
Heat Toxin Stagnation
Damp-heat Obstruction
Yang Qi Deficiency
Spleen failing to Control
Blood
Turbid Dampness
Overflowing
Yin and Yang Separation
and Collapse
Liver and Kidney Yin
Deficiency
Liver Depression and
Spleen Deficiency
Dampness Obsructing
the Spleen and Stomach
Stasis-heat and Phlegm
Obstruction
Liver Depression and Qi
Stgnation
Total
Stage (n, %)
Early
82
22
12
2
6
4
8
10
2
4
0
140
58.57
15.71
8.57
1.43
4.29
2.86
5.71
7.14
1.43
2.86
0.00
100.00
Middle
36
20
22
4
7
11
12
4
6
2
4
106
33.96
18.87
20.75
3.77
6.60
10.38
11.32
3.77
5.66
1.89
3.77
100.00
Later
16
10
32
5
11
16
6
4
6
0
4
78
20.51
12.82
41.03
6.41
14.10
20.51
7.69
5.13
7.69
0.00
5.13
100.00
Total Percentage
(%)
41.36
16.05
20.37
3.40
7.41
9.57
8.02
5.56
4.32
1.85
2.47
100.00
Notes: overall distribution of different stages: Heat Toxin Stag. P<0.01, χ2=33.469; Yang Qi Def. P<0.01, χ2=32.541
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Group of the Chinese Medical Association issued the
first Diagnostic and Treatment Guidelines for Liver
Failure.4 In 2009, the APASAL conference issued the
Acute-on-chronic Liver Failure Consensus and Discus-
sion Draft, which differentiated ACLF from chronic
liver failure (CLF). The Acute-on-chronic Liver Failure
Consensus and Discussion Draft defined ACLF' s diag-
nostic criteria from a functional aspect and discussed
details regarding ACLF (for example, definition, cause,
pathophysiology, clinical manifestations, diagnosis, dif-
ferential diagnosis, prognosis, and treatment). The is-
sued guidelines and consensus mentioned above re-
markably improved the understanding, diagnosis, and
treatment of ACLF.
Most scholars believe that chronic severe hepatitis dis-
cussed in the 10th National Viral Hepatitis Conference
in 2000, Xi'an includes ACLF and CLF which were dis-
cussed in the Guideline of Diagnosis and Treatment of
Liver Failure in 2006. However, CLF is chronic liver de-
compensation on the basis of cirrhosis accompanied by
ascites or portal hypertension, dysfunction of coagula-
tion, and hepatic encephalopathy.12 ACLF and CLF have
remarkable differences in results of laboratory examina-
tions, complications and prognosis, such as alanine ami-
notransferase, aspartate aminotransferase, albumin, glob-
ulin, coagulation parameters, cholinesterase, complica-
tions of hepatic encephalopathy, upper digestive tract
hemorrhage, ascites, spontaneous bacterial peritonitis,
infection, and mortality.13-14 In summary, the clinical
manifestations, treatment, and prognosis of ACLF and
CLF have significant differences and should be differenti-
ated, which also applies in the study of TCM patterns.
The differentiation for ACLF and CLF applies not only
for conception, but also for treatment and prognosis ac-
cording to differentiation.
Recent studies on the TCM patterns in China have
mainly focused on chronic severe hepatitis which were
discussed in the 2000 Xi'an Conference. It is impor-
tant to determine the distribution of TCM patterns for
HB-ACLF because the Guideline of the Diagnosis and
Treatment of Liver Failure confirmed new diagnostic
criteria of ACLF and CLF.
Our study showed that the excessive patterns com-
prised the major part of the early stage of HB-ACLF, (e.
g., Heat Toxin Stagnation Pattern, Damp-heat Ob-
struction Pattern, Yang Qi Deficiency Pattern, and Liv-
er and Kidney Yin Deficiency Pattern). In the late stage
of HB-ACLF, the deficient patterns comprised the
greatest proportion (e.g., Yang Qi Deficiency Pattern,
Heat Toxin Stagnation Pattern, Damp-heat Obstruc-
tion Pattern, and Liver and Kidney Yin Deficiency Pat-
tern). In the middle stage, distribution of TCM pat-
terns for HB-ACLF were prone to an intermediate
state of excessive and deficient patterns with the Heat
Toxin Stagnation Pattern, the Damp-heat Obstruction
Pattern, the Yang Qi Deficiency Pattern, and the Liver
and Kidney Yin Deficiency Pattern. The general fre-
quency of TCM patterns in HB-ACLF can be present-
ed as follows: Heat Toxin Stagnation Pattern (134/324,
41.36% ), Damp-heat Obstruction Pattern (66/324,
20.37% ), Yang Qi Deficiency Pattern (52/324,
16.05%) and Liver and Kidney Yin Deficiency Pattern
(26/324, 8.02%). Our results indicated that the TCM
patterns in HB-ACLF transformed in each stage. The
Heat Toxin Stagnation Pattern was the representative
pattern in the early stage, and it was significantly more
prevalent than that in the middle and late stages. The
Yang Qi Deficiency Pattern was the representative pat-
tern in the late stage, and it was significantly more prev-
alent than that in the early and middle stages. Other
patterns, including Damp-heat Obstruction, Liver and
Kidney Yin Deficiency, Liver Depression and Spleen
Deficiency, Dampness Obstructing the Spleen and
Stomach, Stasis-heat and Phlegm Obstruction, and Liv-
er Depression with Qi Stagnation were not significant-
ly different among the early, middle and late stages of
HB-ACLF.
HB-ACLF has different immunological backgrounds
in different stages according to modern medicine. In
the early stage of HB-ACLF, the immune system induc-
es massive and submassive necrosis of liver cells as a re-
sult of immune hyperfunction.15 Studies indicate that
clearing therapy of TCM can decrease the mortality of
HB-ACLF in the early stage by eliminating immune
complexes and endotoxin, inhibiting inflammation,
promoting regeneration, and ameliorating symptoms
as a result of suppression of immune hyperfunction.16
In the late stage of HB-ACLF, immune hypofunction
develops, with significantly less total lymphocytes,
CD4+, CD8+T cells, and NK cells compared with those
in the early stage. Therefore, the lymphocyte subset is
an effective marker to predict the prognosis of
HB-ACLF patients. HB-ACLF death cases were more
concentrated in the late stage with much less total lym-
phocytes, CD4 + , CD8 + T cells, and NK cells than
those in cases that survive (P<0.05), which demon-
strates that a reduction in immunocompetent cells in
peripheral blood may be the driving factor for deteriora-
tion of HB-ACLF.17 TCM-supplementing therapy less-
ens the mortality of HB-ACLF in the late stage by
blocking inflammation reactions, improving hepato-
cyte regeneration, and reducing secondary infection.18,19
Treatment for HB-ACLF should vary with different
representative patterns in the early and late stages, by
clearing and reducing internal heat in the early stage,
and warming and supplementing organs in the late
stage. In the middle stage of HB-ACLF, a combination
of clearing and warming should be applied according to
our results of not finding any representative patterns.
Our results showed that in different stages of
HB-ACLF, the distribution of the TCM patterns re-
markably varied. HB-ACLF stages can proclaim ups
and downs of not only pathogens but also anti-patho-
genic Qi. In the early stage of HB-ACLF, the pathogen
and anti-pathogenic Qi are both strong and excessive.
In the middle stage, deficiency and excess are mixed. In
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the late stage, anti-pathogenic Qi and the pathogen are
both weak, altering the disease from excessive to defi-
cient with various complications. This transformation
corresponds with general TCM understanding of a
change in disease, for which different measures should
be taken in each stage as follows: reducing the excess
and strengthening the deficiency are important in the
early stage and the late stage, respectively, while in the
middle stage, the combination of relieving and
strengthening should be applied according to pattern
differentiation.
Our study provides new ideas for clinical strategies. For
example, regular treatment for HB-ACLF patients in
the early and late stage could be administered by add-
ing and subtracting components of a root prescription
according to TCM patterns. However, in the middle
stage, there is no representative pattern, and therefore
confirming a root prescription would be difficult, as
well as adding and subtracting components of a root.
Attention should be paid to designing a flexible thera-
py according to pattern differentiation to decrease mor-
tality and increase curative effects.
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